NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14

EDEN PRAIRIE, Minn., Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal first quarter 2023 ended December 31, 2022 and provide a corporate update on February 14, 2023 at 4:30 PM Eastern Time.

(PRNewsfoto/NeuroOne Medical Technologies Corporation)
(PRNewsfoto/NeuroOne Medical Technologies Corporation)

Conference Call and Webcast Information:

Tuesday, February 14, 20234:30 PM Eastern Time

Participant Dial-In:
877-405-1216 / 201-689-8336

Live Webcast: 
Join here

Phone Replay:
877-660-6853 / 201-612-7415, Access ID: 13736384; available through February 28, 2023

Webcast Replay:       
Available for 12 months

About NeuroOne

NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.  For more information, visit



View original content to download multimedia:

SOURCE NeuroOne Medical Technologies Corporation